Thanks for posting. Full text is available through the link you provided.
Agree this study is relatively small (n=119 in each arm), but the results are very encouraging.
Note that baseline Trig levels were 105 (control) and and 117 (treatment arm) (I assume these are means). Those are pretty low numbers to start with. That there is apparently a treatment effect with EPA even when Trig levels start out within the normal range implies that the mechanism may have little to do with Trig reduction. I have not yet read the text fully to know whether the authors conclude reduction of systemic inflammation is somewhere in the chain of causation.
Note also that the EPA dose used here, 1800 mg (the number I have seen most often in these Japanese studies), is much less than the 4 gm dose being used in R-It. Of course, the population is apparently Japanese, so their baseline levels of EPA could be expected to be much higher.
Thanks again for posting. I am even more encouraged about R-It results being good.